People
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Diagnostics and therapeutics for Alzheimer’s disease are on the verge of becoming mainstream medicine. It’s about time, too.
The National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling volunteers in clinical trials for COVID-19 vaccines and monoclonal antibodies.
What if you could get one vaccine that protects you against a wide spectrum of viruses, even viruses we haven’t discovered yet?
On Tuesday, the White House notified Congress and the United Nations of the decision. However, the withdrawal will not be immediate.
IM Therapeutics is developing a personalized, orally available small molecule therapeutic for diabetes. This is a milestone for autoimmune diseases and may be the first time diabetes patients can be preselected for a therapeutic based on whether they carry a specific gene.
Putting your employees and company culture first keeps the focus on inclusion and innovation, giving the company an incredible competitive advantage.
As countries reopen businesses and move toward normalcy, emerging biotech companies in the U.S. and Europe have encountered a mixed bag of experiences.
As of June 29, there were 13 vaccines against COVID-19 in human clinical trials.
In a forthcoming paper, 239 scientists from more than 30 countries are pushing the World Health Organization to pay more attention to the possible airborne spread of SARS-CoV-2.
PRESS RELEASES